Jennison Associates LLC Lowers Stake in Astera Labs, Inc. $ALAB

Jennison Associates LLC lowered its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 63.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 2,630 shares of the company’s stock after selling 4,607 shares during the period. Jennison Associates LLC’s holdings in Astera Labs were worth $438,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Assetmark Inc. lifted its holdings in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank lifted its holdings in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC acquired a new stake in Astera Labs during the 4th quarter worth approximately $33,000. National Bank of Canada FI lifted its holdings in Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares in the last quarter. Finally, Wexford Capital LP acquired a new stake in Astera Labs during the 3rd quarter worth approximately $39,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Down 0.7%

Shares of NASDAQ ALAB opened at $201.25 on Tuesday. The stock has a market cap of $34.47 billion, a PE ratio of 164.96, a price-to-earnings-growth ratio of 3.99 and a beta of 3.34. Astera Labs, Inc. has a 52-week low of $63.40 and a 52-week high of $262.90. The business has a 50-day moving average price of $139.00 and a 200 day moving average price of $153.00.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s revenue was up 91.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have issued reports on ALAB. Rothschild & Co Redburn began coverage on shares of Astera Labs in a report on Friday. They set a “neutral” rating and a $153.00 target price on the stock. Loop Capital began coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Stifel Nicolaus set a $236.00 target price on shares of Astera Labs in a report on Friday. Royal Bank Of Canada reiterated an “outperform” rating and set a $250.00 target price on shares of Astera Labs in a report on Tuesday, April 21st. Finally, Citigroup began coverage on shares of Astera Labs in a report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $199.20.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of Astera Labs stock in a transaction on Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the completion of the transaction, the chief executive officer owned 4,069,134 shares in the company, valued at approximately $713,929,560.30. This represents a 0.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,064,888 shares of company stock valued at $150,764,723 in the last 90 days. Company insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.